Insights On Clinical Technologies

  1. The Hidden Truths About Prepaid Cards In Clinical Trials 3/24/2025

    Prepaid debit cards have revolutionized participant payments in clinical trials. However, questions are being raised about transparency and who sets fees.

  2. The End Of Clinical Trial-And-Error: AI-Powered Design For Protocol Certainty 10/2/2025

    Discover how AI-powered predictive analytics and protocol optimization tools can improve trial feasibility, forecast patient enrollment, and reduce burden.

  3. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

    Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.

  4. Securing Sponsor Reimbursement For CRIO Fees 12/11/2025

    Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.

  5. eCOA Best Practices For Crohn's And UC Trials 1/27/2025

    Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.

  6. The Case For Cognitive Assessments In Phase 1 Clinical Trials 7/16/2024

    Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.

  7. The Case For A New Paradigm In Geographic Atrophy Clinical Trials 10/15/2025

    Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.

  8. Do CROs Need To Reinvent Themselves In 2025? 3/21/2025

    Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

  9. Utilizing Curated Data To Boost Your Urology Research And Innovation 5/28/2025

    Obtain robust data from a reputable source to boost your urology research and propel your life science company's innovation in the urology space.

  10. Transforming Oncology Trials With Next-Gen eCOA 6/9/2025

    With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.